Hero image with Pittsburgh background https://pittplusme.org/study/1978

We're sorry. This study is closed and no longer recruiting participants.

STUDY BASICS

Are you 18-24 years old and getting ready to start a new hormonal method of birth control (depo, IUD, implant)? You may be able to participate in a study to collect samples to evaluate the impact that hormonal (birth control) methods have on immune response and HIV risk. This study involves 4 visits over 3 months. Compensation is provided.


IRB: STUDY19030216B
- Assessing the Impact of DMPA, Etonogestrel Implant and Levonorgestrel Intrauterine Device on Markers of Increased HIV Infectivity in an Adolescent Population

Age Range
AGE:   18-24
Gender List
SEX ASSIGNED AT BIRTH:   Female
Duration
DURATION:  3 months
VISITS:  4
Location
LOCATION:  UPMC Magee-Womens Hospital - Oakland
Compensation
COMPENSATION:  $240
Location
PHONE NUMBER: 1-866-438-8230
SHARE STUDY
Printer Printer   Email A FriendEmail A Friend   ShareShare   TweetTweet   Linked-InLinked-In

INTERESTED?

Visit https://pittplusme.org/study/1978 and click on "I'm Interested" or call 1-866-438-8230.

LEARN MORE

PittPlusMe.org
1-866-438-8230
PittPlusMe@pitt.edu
@PittPlusMe
@PittPlusMe

MEET THE RESEARCHER


Katherine Bunge

Katherine Bunge, MD, MPH, is an Assistant Professor, Department of Obstetrics, Gynecology & Reproductive Sciences at Magee-Womens Hospital of UPMC. Dr. Bunge's research interests include investigating the safety of vaginal microbicide products, expanding contraceptive options in HIV prevention trials, and developing alternative microbicide formulations. Dr. Bunge earned her medical and masters degrees from the Johns Hopkins School of Medicine, completed her residency at Northwestern Memorial Hospital, and performed her fellowship at Magee-Womens Hospital of UPMC.